NO974480D0 - Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme - Google Patents
Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidismeInfo
- Publication number
- NO974480D0 NO974480D0 NO974480A NO974480A NO974480D0 NO 974480 D0 NO974480 D0 NO 974480D0 NO 974480 A NO974480 A NO 974480A NO 974480 A NO974480 A NO 974480A NO 974480 D0 NO974480 D0 NO 974480D0
- Authority
- NO
- Norway
- Prior art keywords
- vitamin
- medicament
- derivatives
- manufacture
- treatment
- Prior art date
Links
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 title 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960002061 ergocalciferol Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 title 1
- 235000001892 vitamin D2 Nutrition 0.000 title 1
- 239000011653 vitamin D2 Substances 0.000 title 1
- 150000003706 vitamin D4 derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/415,488 US5602116A (en) | 1988-08-02 | 1995-04-03 | Method for treating and preventing secondary hyperparathyroidism |
PCT/US1996/004553 WO1996031215A1 (en) | 1995-04-03 | 1996-04-03 | Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974480D0 true NO974480D0 (no) | 1997-09-29 |
NO974480L NO974480L (no) | 1997-11-14 |
Family
ID=23645881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974480A NO974480L (no) | 1995-04-03 | 1997-09-29 | Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme |
Country Status (18)
Country | Link |
---|---|
US (3) | US5602116A (no) |
EP (1) | EP0820290B1 (no) |
JP (1) | JP3529790B2 (no) |
KR (1) | KR100432265B1 (no) |
CN (1) | CN1214795C (no) |
AU (1) | AU719773B2 (no) |
BR (1) | BR9604940A (no) |
CA (1) | CA2217260C (no) |
DE (1) | DE69629184T2 (no) |
ES (1) | ES2206570T3 (no) |
FI (1) | FI973868A (no) |
HK (1) | HK1008180A1 (no) |
HU (1) | HUP9801777A3 (no) |
MX (1) | MX9707535A (no) |
NO (1) | NO974480L (no) |
NZ (1) | NZ316662A (no) |
PL (1) | PL322613A1 (no) |
WO (1) | WO1996031215A1 (no) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6503893B2 (en) * | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
BR9815442A (pt) * | 1997-02-13 | 2001-08-21 | Bone Care Int Inc | Liberação terapêutica dirigida de compostos de vitamina d |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US5962030A (en) | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
ES2368824T3 (es) * | 1998-03-27 | 2011-11-22 | Oregon Health & Science University | Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos. |
AU6044699A (en) * | 1998-09-17 | 2000-04-03 | Akesis Pharmaceuticals, Inc. | Compositions and methods for treatment of glucose metabolism disorders |
US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
EP1276482B1 (en) * | 2000-03-02 | 2008-01-16 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Combination chemotherapy |
EP1301479A2 (en) * | 2000-07-18 | 2003-04-16 | Bone Care International, Inc. | STABILIZED 1$g(a)-HYDROXY VITAMIN D |
JP2004532801A (ja) * | 2000-10-13 | 2004-10-28 | アボット・ラボラトリーズ | ビタミンd化合物の初回量を決定する方法 |
US7129230B2 (en) | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
KR100438254B1 (ko) * | 2001-03-29 | 2004-07-02 | 아이큐어 주식회사 | 비타민 d 유사체를 포함하는 매트릭스형 경피흡수제제 |
ES2192136B1 (es) * | 2002-01-04 | 2005-03-16 | Italfarmaco, S.A. | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. |
US7566696B2 (en) | 2002-09-05 | 2009-07-28 | Wisconsin Alumni Research Foundation | Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
WO2004028515A1 (en) * | 2002-09-26 | 2004-04-08 | Young-Kweon Choi | Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
US20060216358A1 (en) * | 2003-05-07 | 2006-09-28 | Christian Hansen | Controlled release composition containing a strontium salt |
EP2266585B1 (en) * | 2003-05-07 | 2013-06-26 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
JP4861817B2 (ja) * | 2003-05-07 | 2012-01-25 | オステオロジックス エイ/エス | 軟骨および/または骨の症状の予防および/または治療のためのストロンチウムを用いる併用治療 |
US20050239756A1 (en) * | 2004-04-23 | 2005-10-27 | Bone Care International, Inc. | Methods of treating various vitamin D metabolism conditions with 1alpha-hydroxyvitamin D2 |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
CA2595368A1 (en) * | 2005-02-14 | 2006-08-24 | Wisconsin Alumni Research Foundation | Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
WO2007047327A2 (en) * | 2005-10-12 | 2007-04-26 | Proventiv Therapeutics, Llc | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
HUE028029T2 (en) * | 2006-01-30 | 2016-11-28 | Panion & Bf Biotech Inc | A method of treating chronic kidney disease |
SI3095447T1 (sl) * | 2006-02-03 | 2022-02-28 | Opko Renal, Llc | Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3 |
JP5563296B2 (ja) | 2006-06-21 | 2014-07-30 | プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー | 二次性副甲状腺機能亢進症の治療及び予防方法 |
AU2007325387B2 (en) * | 2006-11-16 | 2014-04-03 | Kai Pharmaceuticals, Inc. | Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
CA2943032C (en) | 2007-04-25 | 2019-05-07 | Cytochroma Inc. | Oral controlled release compositions comprising vitamin d compound and waxy carrier |
CA2683514C (en) | 2007-04-25 | 2019-07-09 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
US8592401B2 (en) * | 2007-04-25 | 2013-11-26 | Proventiv Therapeutics, Llc | Methods and compounds for vitamin D therapy |
CN101668532B (zh) * | 2007-04-25 | 2014-08-20 | 赛特克罗公司 | 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途 |
CA2714996C (en) | 2008-04-02 | 2020-04-07 | Cytochroma Inc. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
KR20120046753A (ko) | 2009-07-21 | 2012-05-10 | 케릭스 바이오파마슈티컬스 인코포레이티드 | 구연산철 투여형태 |
PL2459208T3 (pl) | 2009-07-29 | 2017-05-31 | Kai Pharmaceuticals, Inc. | Środki lecznicze zmniejszające poziom parathormonu |
US7886904B1 (en) * | 2009-07-30 | 2011-02-15 | Owens Corning Intellectual Capital, Llc | Loosefill package for blowing wool machine |
WO2011123476A1 (en) | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
CA2698160C (en) * | 2010-03-30 | 2017-07-25 | Alphora Research Inc. | Stabilized doxercalciferol and process for manufacturing the same |
CA2796505C (en) * | 2010-04-16 | 2018-12-11 | Baxter International Inc. | Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis |
RS55503B1 (sr) | 2011-06-08 | 2017-05-31 | Kai Pharmaceuticals Inc | Terapijska sredstva za regulisanje fosfora u serumu |
CN104168955A (zh) | 2011-11-10 | 2014-11-26 | 凯伊药品公司 | 拟钙剂及其使用方法 |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
CN106029067A (zh) * | 2014-02-26 | 2016-10-12 | 日本脏器制药株式会社 | 慢性肾病的发展抑制或改善剂 |
PE20170392A1 (es) | 2014-08-07 | 2017-04-07 | Opko Ireland Global Holdings Ltd | Terapia adjuntiva con 25-hidroxi vitamina d |
JP6520510B2 (ja) * | 2015-07-15 | 2019-05-29 | 富士ゼロックス株式会社 | 情報処理装置及び情報処理プログラム |
CR20180510A (es) | 2016-03-28 | 2019-05-15 | Opko Ireland Global Holdings Ltd | Método de tratamiento con vitamina d |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3907843A (en) * | 1974-06-14 | 1975-09-23 | Wisconsin Alumni Res Found | 1{60 -Hydroxyergocalciferol and processes for preparing same |
US4202829A (en) * | 1978-01-05 | 1980-05-13 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4195027A (en) * | 1978-01-16 | 1980-03-25 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4260549A (en) * | 1979-05-21 | 1981-04-07 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4225596A (en) * | 1978-10-13 | 1980-09-30 | Wisconsin Alumni Research Foundation | Method for treating calcium imbalance and improving calcium absorption in mammals |
US4234495A (en) * | 1979-09-10 | 1980-11-18 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxyvitamin D compounds from 1α-hydroxy-3,5-cyclovitamin D compounds |
US4554106A (en) * | 1984-11-01 | 1985-11-19 | Wisconsin Alumni Research Foundation | Method for preparing 1α-hydroxyvitamin D compounds |
US4555364A (en) * | 1984-11-01 | 1985-11-26 | Wisconsin Alumni Research Foundation | Method for preparing 1-hydroxyvitamin D compounds |
IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
US5063221A (en) * | 1989-04-05 | 1991-11-05 | Chugai Seiyaku Kabushiki Kaisha | Treatment for hyperparathyroidism with use of vitamin d derivatives |
WO1992005130A1 (en) * | 1990-09-21 | 1992-04-02 | Lunar Corporation | NOVEL 1α-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES |
AU1247592A (en) * | 1991-01-08 | 1992-08-17 | Lunar Corporation | Methods for preparation and use of 1alpha,24-dihydroxy vitamin d2 |
DK0503630T3 (da) * | 1991-03-13 | 1996-01-29 | Kuraray Co | Cyclohexantriolderivater |
EP0631500B1 (en) * | 1992-01-29 | 1998-04-22 | Bone Care International, Inc. | 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 |
EP0562497A1 (en) * | 1992-03-27 | 1993-09-29 | Nisshin Flour Milling Co., Ltd. | 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions |
AU4841193A (en) * | 1992-08-28 | 1994-03-29 | Lunar Corporation | 1alpha,24(S)-dihydroxy vitamin D2, its formation and use |
US5350745A (en) * | 1993-01-29 | 1994-09-27 | Lunar Corporation | Treatment of myocardial failure |
-
1995
- 1995-04-03 US US08/415,488 patent/US5602116A/en not_active Expired - Lifetime
-
1996
- 1996-04-03 EP EP96910720A patent/EP0820290B1/en not_active Expired - Lifetime
- 1996-04-03 HU HU9801777A patent/HUP9801777A3/hu unknown
- 1996-04-03 CA CA002217260A patent/CA2217260C/en not_active Expired - Lifetime
- 1996-04-03 DE DE69629184T patent/DE69629184T2/de not_active Expired - Lifetime
- 1996-04-03 AU AU53840/96A patent/AU719773B2/en not_active Expired
- 1996-04-03 CN CNB961940980A patent/CN1214795C/zh not_active Expired - Lifetime
- 1996-04-03 WO PCT/US1996/004553 patent/WO1996031215A1/en active IP Right Grant
- 1996-04-03 BR BR9604940A patent/BR9604940A/pt not_active Application Discontinuation
- 1996-04-03 ES ES96910720T patent/ES2206570T3/es not_active Expired - Lifetime
- 1996-04-03 JP JP53044696A patent/JP3529790B2/ja not_active Expired - Lifetime
- 1996-04-03 PL PL96322613A patent/PL322613A1/xx unknown
- 1996-04-03 KR KR1019970706941A patent/KR100432265B1/ko not_active IP Right Cessation
- 1996-04-03 NZ NZ316662A patent/NZ316662A/en unknown
-
1997
- 1997-02-11 US US08/798,958 patent/US5707980A/en not_active Expired - Lifetime
- 1997-08-08 US US08/907,658 patent/US5861386A/en not_active Expired - Fee Related
- 1997-09-29 NO NO974480A patent/NO974480L/no not_active Application Discontinuation
- 1997-10-01 MX MX9707535A patent/MX9707535A/es unknown
- 1997-10-02 FI FI973868A patent/FI973868A/fi unknown
-
1998
- 1998-07-14 HK HK98109130A patent/HK1008180A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU719773B2 (en) | 2000-05-18 |
HUP9801777A2 (hu) | 1998-11-30 |
ES2206570T3 (es) | 2004-05-16 |
DE69629184D1 (de) | 2003-08-28 |
KR100432265B1 (ko) | 2004-09-10 |
US5707980A (en) | 1998-01-13 |
AU5384096A (en) | 1996-10-23 |
FI973868A0 (fi) | 1997-10-02 |
HUP9801777A3 (en) | 1999-05-28 |
DE69629184T2 (de) | 2004-05-06 |
JP3529790B2 (ja) | 2004-05-24 |
CN1185109A (zh) | 1998-06-17 |
NO974480L (no) | 1997-11-14 |
EP0820290A1 (en) | 1998-01-28 |
US5602116A (en) | 1997-02-11 |
PL322613A1 (en) | 1998-02-02 |
FI973868A (fi) | 1997-10-02 |
CN1214795C (zh) | 2005-08-17 |
US5861386A (en) | 1999-01-19 |
BR9604940A (pt) | 1998-06-09 |
CA2217260A1 (en) | 1996-10-10 |
EP0820290B1 (en) | 2003-07-23 |
CA2217260C (en) | 2000-08-01 |
KR19980703537A (ko) | 1998-11-05 |
JPH11503164A (ja) | 1999-03-23 |
MX9707535A (es) | 1998-07-31 |
WO1996031215A1 (en) | 1996-10-10 |
HK1008180A1 (en) | 1999-05-07 |
NZ316662A (en) | 2001-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974480D0 (no) | Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme | |
NO961006D0 (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
NO20040145L (no) | Anvendelse av benzensulfonamidderivater for fremstilling av et medikament | |
AU2549797A (en) | Xanthone analogs for the treatment of infectious diseases | |
FI954007A0 (fi) | Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena | |
NO973243D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer | |
NO911956L (no) | Fremgangsmaate for fremstilling av oxydant sensitive og insensitive, aromatiske estere som inhibitorer for human neutrofil elastase | |
AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
DK182989D0 (da) | Underlag, isaer til bevaegelseshaemmede personer | |
EP0740936A3 (fr) | Utilisation des dérivés du benzopyrane pour l' obtention de compositions pharmaceutiques destinées au traitement des pathologies liées a l'énchangeur Cl-/HCO3-,Na+ indépendant | |
EE03384B1 (et) | Melatoniini kasutamine ravimi tootmiseks | |
EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO305305B1 (no) | Anvendelse av rhamnan, rhamnose eller en rhamnoseoligomer for fremstilling av et medikament | |
NO304110B1 (no) | FremgangsmÕte for fremstilling av glutardialdehyd | |
NO903347L (no) | 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler. | |
AU4081393A (en) | Medicaments for the treatment of anxiety | |
NO20003393D0 (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
AU7726796A (en) | Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma | |
NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
ZA967281B (en) | Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |